Insider · CIK 0001174533
Michael F Demane
director
Files at NVRO (NEVRO CORP). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | NVRO NEVRO CORP | DDisposition to issuer Common Stock | -61,863 | - | - | 0 | Apr 3, 2025 |
| Apr 3, 2025 | NVRO NEVRO CORP | DDisposition to issuer Common Stockindirect: See footnote | -164,344 | - | - | 0 | Apr 3, 2025 |
| Apr 3, 2025 | NVRO NEVRO CORP | DDisposition to issuer Common Stockindirect: See footnote | -219,145 | - | - | 0 | Apr 3, 2025 |
| Apr 3, 2025 | NVRO NEVRO CORP | DDisposition to issuer Common Stockindirect: See footnote | -58,266 | - | - | 0 | Apr 3, 2025 |
| Dec 31, 2024 | NVRO NEVRO CORP | AGrant or award Common Stock | +7,056 | $0.00 | $0 | 61,863 | Jan 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.